| pubmed-article:16154479 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0150097 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0577559 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0073992 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0600370 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0805586 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C0021461 | lld:lifeskim |
| pubmed-article:16154479 | lifeskim:mentions | umls-concept:C1881212 | lld:lifeskim |
| pubmed-article:16154479 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:16154479 | pubmed:dateCreated | 2005-9-12 | lld:pubmed |
| pubmed-article:16154479 | pubmed:abstractText | This study examined the clinical relevance of fine-particle mass (FPM) delivered from metered dose inhalers (MDIs) to bronchodilatation and bronchoprotection against methacholine challenge by comparing a marketed chlorofluorocarbon (CFC) formulation of salmeterol with an investigational hydrofluoroalkane (HFA)formulation. | lld:pubmed |
| pubmed-article:16154479 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16154479 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16154479 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16154479 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16154479 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:16154479 | pubmed:issn | 0149-2918 | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:AllenDavidD | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:WoodcockAshle... | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:LangleyStephe... | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:SharmaRaj KRK | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:SykesAndrewA | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:McDonnellBarb... | lld:pubmed |
| pubmed-article:16154479 | pubmed:author | pubmed-author:WheelerNeilN | lld:pubmed |
| pubmed-article:16154479 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16154479 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:16154479 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16154479 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16154479 | pubmed:pagination | 1004-12 | lld:pubmed |
| pubmed-article:16154479 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:meshHeading | pubmed-meshheading:16154479... | lld:pubmed |
| pubmed-article:16154479 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16154479 | pubmed:articleTitle | The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study. | lld:pubmed |
| pubmed-article:16154479 | pubmed:affiliation | Medicines Evaluation Unit, North West Lung Centre, Wythenshawe Hospital, Manchester, UK. | lld:pubmed |
| pubmed-article:16154479 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16154479 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:16154479 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:16154479 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
